A widely used sampling device in colorectal cancer screening programmes allows for large-scale microbiome studies
Gut
.
2019 Sep;68(9):1723-1725.
doi: 10.1136/gutjnl-2018-316225.
Epub 2018 Sep 21.
Authors
Dita Gudra
#
1
,
Saeed Shoaie
#
2
3
,
Davids Fridmanis
1
,
Janis Klovins
1
,
Hugo Wefer
2
4
,
Ivars Silamikelis
1
,
Raitis Peculis
1
,
Ineta Kalnina
1
,
Ilze Elbere
1
,
Ilze Radovica-Spalvina
1
,
Rolf Hultcrantz
2
,
Ģirts Šķenders
5
6
,
Marcis Leja
#
5
6
,
Lars Engstrand
#
2
4
Affiliations
1
Latvian Biomedical Research and Study Centre, Riga, Latvia.
2
Centre for Translational Microbiome Research, Department of Microbiology Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
3
Centre for Host-Microbiome Interactions, Dental Institute, King's College London, London, UK.
4
Science for Life Laboratory, Solna, Sweden.
5
Faculty of Medicine, University of Latvia, Riga, Latvia.
6
Institute of Clinical and Preventive Medicine, University of Latvia, Riga, Latvia.
#
Contributed equally.
PMID:
30242040
PMCID:
PMC6709769
DOI:
10.1136/gutjnl-2018-316225
No abstract available
Keywords:
colonic microflora; epidemiology.
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Colorectal Neoplasms*
Early Detection of Cancer
Hemoglobins
Humans
Mass Screening
Microbiota*
Occult Blood
Substances
Hemoglobins